Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial von Leypoldt, Lisa B., Besemer, Britta, Asemissen, Anne Marie, Hänel, Mathias, Blau, Igor Wolfgang, Görner, Martin, Ko, Yon-Dschun, Reinhardt, Hans Christian, Staib, Peter, Mann, Christoph, Lutz, Raphael, Munder, Markus, Graeven, Ullrich, Peceny, Rudolf, Salwender, Hans, Jauch, Anna, Zago, Manola, Benner, Axel, Tichy, Diana, Bokemeyer, Carsten, Goldschmidt, Hartmut, Weisel, Katja C.

Volltext

Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE von Goldschmidt, Hartmut, Baertsch, Marc-Andrea, Schlenzka, Jana, Becker, Natalia, Habermehl, Christina, Hielscher, Thomas, Raab, Marc-Steffen, Hillengass, Jens, Sauer, Sandra, Müller-Tidow, Carsten, Luntz, Steffen, Jauch, Anna, Hose, Dirk, Seckinger, Anja, Brossart, Peter, Goerner, Martin, Klein, Stefan, Schmidt-Hieber, Martin, Reimer, Peter, Graeven, Ullrich, Fenk, Roland, Haenel, Mathias, Martin, Hans, Lindemann, Hans W., Scheid, Christoph, Nogai, Axel, Salwender, Hans, Noppeney, Richard, Besemer, Britta, Weisel, Katja

Volltext

SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapy von Martac, Ioana, Beer, Sina A, Schenk, Aileen, Ahmad, Osama, Maier, Claus-Philipp, Demirel, Gülay, Preuß, Beate, Klein, Reinhild, Stanger, Anna M P, Besemer, Britta, Hensen, Luca, Lengerke, Claudia

Volltext

Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma von Schieferdecker, Aneta, Hörber, Sebastian, Ums, Monika, Besemer, Britta, Bokemeyer, Carsten, Peter, Andreas, Weisel, Katja

Volltext

Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial von Salwender, Hans, Elmaagacli, Ahmet, Merz, Maximilian, Miah, Kaya, Benner, Axel, Haenel, Mathias, Jehn, Christian, Mai, Elias K., Bertsch, Uta, Blau, Igor W., Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Raab, Marc S., Luntz, Steffen P., Besemer, Britta, Munder, Markus, Brossart, Peter, Fuhrmann, Stephan, Lindemann, Hans-Walter, Weisel, Katja, Duerig, Jan, Goldschmidt, Hartmut

Volltext

Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial von Salwender, Hans, Weinhold, Niels, Benner, Axel, Miah, Kaya, Merz, Maximilian, Haenel, Mathias, Jehn, Christian, Mai, Elias, Menis, Ekaterina, Blau, Igor, Scheid, Christof, Hose, Dirk, Seckinger, Anja, Luntz, Steffen, Besemer, Britta, Munder, Markus, Brossart, Peter, Glass, Bertram, Lindemann, Hans-Walter, Weisel, Katja, Hanoun, Christine, Schnitzler, Paul, Klemm, Sarah, Goldschmidt, Hartmut, Raab, Marc, Elmaagacli, Ahmet

Volltext

Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma von Bilich, Tatjana, Nelde, Annika, Bauer, Jens, Walz, Simon, Roerden, Malte, Salih, Helmut R., Weisel, Katja, Besemer, Britta, Marcu, Ana, Lübke, Maren, Schuhmacher, Juliane, Neidert, Marian C., Rammensee, Hans-Georg, Stevanović, Stefan, Walz, Juliane S.

Volltext

Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS von Moreau, Philippe, Chari, Ajai, Oriol, Albert, Martinez-Lopez, Joaquin, Haenel, Mathias, Touzeau, Cyrille, Ailawadhi, Sikander, Besemer, Britta, de la Rubia Comos, Javier, Encinas, Cristina, Mateos, Maria-Victoria, Salwender, Hans, Rodriguez-Otero, Paula, Hulin, Cyrille, Karlin, Lionel, Sureda Balari, Anna, Bargay, Joan, Benboubker, Lotfi, Rosiñol, Laura, Tarantolo, Stefano, Terebelo, Howard, Yang, Shiyi, Wang, Jianping, Nnane, Ivo, Qi, Ming, Kosh, Michele, Delioukina, Maria, Goldschmidt, Hartmut

Volltext

Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial von Weisel, Katja C., Scheid, Christof, Zago, Manola, Besemer, Britta, Mai, Elias K., Haenel, Mathias, Duerig, Jan, Munder, Markus, Lindemann, Hans-Walter, Seckinger, Anja, Kunz, Christina, Benner, Axel, Hose, Dirk, Jauch, Anna, Salwender, Hans, Goldschmidt, Hartmut

Volltext

P879: LONG‐TERM FOLLOW‐UP FROM MAJESTEC‐1 OF TECLISTAMAB, A B‐CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)... von Sidana, Surbhi, Moreau, Philippe, Garfall, Alfred, Bhutani, Manisha, Oriol, Albert, Nooka, Ajay, Martin, Tom, Rosiñol Dachs, Laura, Mateos, Maria‐Victoria, Bahlis, Nizar J, Popat, Rakesh, Besemer, Britta, Martinez‐Lopez, Joaquín, Krishnan, Amrita, Delforge, Michel, Trancucci, Danielle, Verona, Raluca, Stephenson, Tara, Chastain, Katherine, Donk, Niels W.C.J.

Volltext

P979: PATIENT‐REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL‐WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE‐CLASS EXPOSED RELAPSED/REFRACTORY M... von Moreau, Philippe, Donk, Niels W.C.J., Delforge, Michel, Einsele, Hermann, De Stefano, Valerio, Perrot, Aurore, Besemer, Britta, Pawlyn, Charlotte, Karlin, Lionel, Manier, Salomon, Leleu, Xavier, Thilakarathne, Pushpike, Diels, Joris, Gries, Katharine, Erler‐Yates, Nichola, Nimwegen, Kirsten, Morano, Raúl, Strulev, Vadim, Haddad, Imene, Kobos, Rachel, Smit, Jennifer, Marshall, Alexander, Slavcev, Mary, Mateos, Maria‐Victoria, Weisel, Katja

Volltext

P883: ALNUCTAMAB (ALNUC; BMS‐986349; CC‐93269), A BCMA × CD3 T‐CELL ENGAGER, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): LATEST RESULTS FROM A PHASE 1 FIRST... von Wong, Sandy W., Bar, Noffar, Victoria Mateos, María, Ribas, Paz, Hansson, Markus, Paris, Laura, Hofmeister, Craig, Rodriguez‐Otero, Paula, Aranzazu Bermúdez, Maria, Santoro, Armando, Yee, Andrew J., Creignou, Maria, Encinas, Cristina, Cerchione, Claudio, Rubia, Javier, Oriol, Albert, Ferstl, Barbara, Besemer, Britta, Chen, Jinjie, Chung, Alexander, Boss, Isaac W., Gaudy, Allison, LI, Shaoyi, Hsu, Kevin, Godwin, Colin, Burgess, Michael R., San‐Miguel, Jesús, Jose Costa, Luciano

Volltext

Teclistamab in Relapsed or Refractory Multiple Myeloma von Moreau, Philippe, Garfall, Alfred L., van de Donk, Niels W.C.J., Nahi, Hareth, San-Miguel, Jesús F., Oriol, Albert, Nooka, Ajay K., Martin, Thomas, Rosinol, Laura, Chari, Ajai, Karlin, Lionel, Benboubker, Lotfi, Mateos, Maria-Victoria, Bahlis, Nizar, Popat, Rakesh, Besemer, Britta, Martínez-López, Joaquín, Sidana, Surbhi, Delforge, Michel, Pei, Lixia, Trancucci, Danielle, Verona, Raluca, Girgis, Suzette, Lin, Shun X.W., Olyslager, Yunsi, Jaffe, Mindy, Uhlar, Clarissa, Stephenson, Tara, Van Rampelbergh, Rian, Banerjee, Arnob, Goldberg, Jenna D., Kobos, Rachel, Krishnan, Amrita, Usmani, Saad Z.

Volltext

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma von Leypoldt, Lisa B, Tichy, Diana, Besemer, Britta, Hänel, Mathias, Raab, Marc S, Mann, Christoph, Munder, Markus, Reinhardt, Hans Christian, Nogai, Axel, Görner, Martin, Ko, Yon-Dschun, de Wit, Maike, Salwender, Hans, Scheid, Christof, Graeven, Ullrich, Peceny, Rudolf, Staib, Peter, Dieing, Annette, Einsele, Hermann, Jauch, Anna, Hundemer, Michael, Zago, Manola, Požek, Ema, Benner, Axel, Bokemeyer, Carsten, Goldschmidt, Hartmut, Weisel, Katja C

Volltext

A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma von Giesen, Nicola, Chatterjee, Manik, Scheid, Christof, Poos, Alexandra M., Besemer, Britta, Miah, Kaya, Benner, Axel, Becker, Nicole, Moehler, Thomas, Metzler, Ivana, Khandanpour, Cyrus, Seidel-Glaetzer, Andrea, Trautmann-Grill, Karolin, Kortüm, K. Martin, Müller-Tidow, Carsten, Mechtersheimer, Gunhild, Goeppert, Benjamin, Stenzinger, Albrecht, Weinhold, Niels, Goldschmidt, Hartmut, Weisel, Katja, Raab, Marc S.

Volltext

75/m mit Zufallsbefund eines Serum-M-Gradienten von Stehle, Michael, Besemer, Britta

Volltext

75/m mit Zufallsbefund eines Serum-M-Gradienten: Vorbereitung auf die Facharztprüfung: Fall 18 von Stehle, Michael, Besemer, Britta

Volltext

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients von Mai, Elias K., Hielscher, Thomas, Bertsch, Uta, Salwender, Hans J., Zweegman, Sonja, Raab, Marc S., Munder, Markus, Pantani, Lucia, Mancuso, Katia, Brossart, Peter, Beksac, Meral, Blau, Igor W., Dürig, Jan, Besemer, Britta, Fenk, Roland, Reimer, Peter, van der Holt, Bronno, Hänel, Mathias, von Metzler, Ivana, Graeven, Ullrich, Müller-Tidow, Carsten, Boccadoro, Mario, Scheid, Christof, Dimopoulos, Meletios A., Hillengass, Jens, Weisel, Katja C., Cavo, Michele, Sonneveld, Pieter, Goldschmidt, Hartmut

Volltext

Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma von Grieb, Nora, Oeser, Alexander, Ferle, Maximilian, Hanke, Franziska, Flossdorf, Sarah, Sauer, Sandra, Goldschmidt, Hartmut, Müller-Tidow, Carsten, Salwender, Hans-Jürgen, Fenk, Roland, Engelhardt, Monika, Zeiser, Robert, Vucinic, Vladan, Franke, Georg-Nikolaus, Blau, Igor Wolfgang, Teschner, Daniel, Einsele, Hermann, Kimmich, Christoph, Kull, Miriam, Besemer, Britta, Gagelmann, Nico, Kröger, Nicolaus, Neumuth, Thomas, Platzbecker, Uwe, Merz, Maximilian

Volltext

Real-World Analysis of Teclistamab in 115 RRMM Patients from Germany von Riedhammer, Christine, Bassermann, Florian, Besemer, Britta, Bewarder, Moritz, Brunner, Franziska, Carpinteiro, Alexander, Einsele, Hermann, Faltin, Josefine, Frenking, Jan, Gezer, Deniz, Goldman-Mazur, Sarah, Hanel, Mathias, Hoegner, Marion, Kortüm, K. Martin, Krönke, Jan, Kull, Miriam, Leitner, Theo, Mann, Christoph, Mecklenbrauck, Rabea, Merz, Maximilian, Morgner, Anke, Nogai, Axel, Raab, Marc S., Teipel, Raphael, Wäsch, Ralph, Rasche, Leo

Volltext